Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).
about
Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entry.Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate LigandsThe dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerizationChronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function.Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1)Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.The structural role of receptor tyrosine sulfation in chemokine recognition.What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer.Mechanisms of Regulation of the Chemokine-Receptor Network.Synthesis of polymers and nanoparticles bearing polystyrene sulfonate brushes for chemokine binding.Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells.Chemoselective peptide ligation-desulfurization at aspartate.Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration.
P2860
Q33652172-A27E5BA9-39F4-40F4-8AA0-0037C0BF9075Q35194597-AB5BEE93-D847-4C39-87BF-34B6A8906431Q35415654-8DCC057A-B670-41FC-AF1B-F1B5BDFD90E5Q35685184-429286C9-A092-46FD-9014-1ADF42A3BCACQ36530735-E2E83542-3BF2-484B-8333-091392767AF6Q36677145-660BFE23-A25A-4044-81BD-A362FBB44425Q36742094-F4723A93-6836-4220-A990-467CBA0113FBQ36796931-96F55D93-CAA4-4113-A00A-68ED932760F4Q37198858-3FA7101F-6BFD-4E8B-AD81-89457981A000Q38151741-C99B555A-C378-4377-8599-687D76F2582FQ38680670-FF681144-180F-42A0-B9CB-AD16AE145352Q38965249-22A7538B-FB47-46EB-9EC1-58414FBE072DQ39126530-DEBFD721-9949-4B14-9EE1-7D87943554C7Q40734493-FF966F80-EE5E-4C31-A2B3-55D37AC4B2E0Q43010856-2448440A-1EF2-4345-9FFC-AC7BD25D86E2Q45892251-F81A7964-6307-4BD0-91AF-019C7146CBFAQ45930874-5AA5AE3B-47F1-4FCF-A81F-48056483C3C5Q50261941-02AD5D28-9B75-4DFA-BF93-0890551B9C0E
P2860
Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@ast
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@en
type
label
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@ast
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@en
prefLabel
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@ast
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@en
P2093
P2860
P50
P356
P1476
Design and receptor interactio ...... oattractant protein-1 (MCP-1).
@en
P2093
Ann Marie Carrick
Christopher Boston
Deni Taleski
Jamie Wedderburn
Joshua H Y Tan
Justin P Ludeman
Richard J Payne
Todd R Parody
P2860
P304
14692-14702
P356
10.1074/JBC.M111.334201
P407
P577
2012-03-06T00:00:00Z